A U.S. based leading pharmaceutical company approached Freyr for assistance in filing original IND application along with its amendments to the USFDA. The client was facing challenges, as there were a large volume of Module 4 and 5 documents to be addressed in a short span of time. Freyr assisted the client with end-to-end publishing activities by adhering to the timelines.
Read the case study to know about Freyr’s approach of dealing with IND applications with zero deficiency.
Fill the form below to download the Case Study
